The gut microbiome in human neurological disease: A review.
Identifieur interne : 000042 ( PubMed/Corpus ); précédent : 000041; suivant : 000043The gut microbiome in human neurological disease: A review.
Auteurs : Helen Tremlett ; Kylynda C. Bauer ; Silke Appel-Cresswell ; Brett B. Finlay ; Emmanuelle WaubantSource :
- Annals of neurology [ 1531-8249 ] ; 2017.
Abstract
Almost half the cells and 1% of the unique genes found in our bodies are human, the rest are from microbes, predominantly bacteria, archaea, fungi, and viruses. These microorganisms collectively form the human microbiota, with most colonizing the gut. Recent technological advances, open access data libraries, and application of high-throughput sequencing have allowed these microbes to be identified and their contribution to neurological health to be examined. Emerging evidence links perturbations in the gut microbiota to neurological disease, including disease risk, activity, and progression. This review provides an overview of the recent advances in microbiome research in relation to neuro(auto)immune and neurodegenerative conditions affecting humans, such as multiple sclerosis, neuromyelitis optica spectrum disorders, Parkinson disease, Alzheimer disease, Huntington disease, and amyotrophic lateral sclerosis. Study design and terminology used in this rapidly evolving, highly multidisciplinary field are summarized to empower and engage the neurology community in this "newly discovered organ." Ann Neurol 2017;81:369-382.
DOI: 10.1002/ana.24901
PubMed: 28220542
Links to Exploration step
pubmed:28220542Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The gut microbiome in human neurological disease: A review.</title>
<author><name sortKey="Tremlett, Helen" sort="Tremlett, Helen" uniqKey="Tremlett H" first="Helen" last="Tremlett">Helen Tremlett</name>
<affiliation><nlm:affiliation>Faculty of Medicine (Neurology) and the Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, British Columbia, Canada.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Bauer, Kylynda C" sort="Bauer, Kylynda C" uniqKey="Bauer K" first="Kylynda C" last="Bauer">Kylynda C. Bauer</name>
<affiliation><nlm:affiliation>Microbiology and Immunology, Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Appel Cresswell, Silke" sort="Appel Cresswell, Silke" uniqKey="Appel Cresswell S" first="Silke" last="Appel-Cresswell">Silke Appel-Cresswell</name>
<affiliation><nlm:affiliation>Faculty of Medicine (Neurology) and the Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, British Columbia, Canada.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Finlay, Brett B" sort="Finlay, Brett B" uniqKey="Finlay B" first="Brett B" last="Finlay">Brett B. Finlay</name>
<affiliation><nlm:affiliation>Microbiology and Immunology, Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Waubant, Emmanuelle" sort="Waubant, Emmanuelle" uniqKey="Waubant E" first="Emmanuelle" last="Waubant">Emmanuelle Waubant</name>
<affiliation><nlm:affiliation>University of California, San Francisco, San Francisco, CA.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28220542</idno>
<idno type="pmid">28220542</idno>
<idno type="doi">10.1002/ana.24901</idno>
<idno type="wicri:Area/PubMed/Corpus">000042</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000042</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">The gut microbiome in human neurological disease: A review.</title>
<author><name sortKey="Tremlett, Helen" sort="Tremlett, Helen" uniqKey="Tremlett H" first="Helen" last="Tremlett">Helen Tremlett</name>
<affiliation><nlm:affiliation>Faculty of Medicine (Neurology) and the Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, British Columbia, Canada.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Bauer, Kylynda C" sort="Bauer, Kylynda C" uniqKey="Bauer K" first="Kylynda C" last="Bauer">Kylynda C. Bauer</name>
<affiliation><nlm:affiliation>Microbiology and Immunology, Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Appel Cresswell, Silke" sort="Appel Cresswell, Silke" uniqKey="Appel Cresswell S" first="Silke" last="Appel-Cresswell">Silke Appel-Cresswell</name>
<affiliation><nlm:affiliation>Faculty of Medicine (Neurology) and the Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, British Columbia, Canada.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Finlay, Brett B" sort="Finlay, Brett B" uniqKey="Finlay B" first="Brett B" last="Finlay">Brett B. Finlay</name>
<affiliation><nlm:affiliation>Microbiology and Immunology, Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Waubant, Emmanuelle" sort="Waubant, Emmanuelle" uniqKey="Waubant E" first="Emmanuelle" last="Waubant">Emmanuelle Waubant</name>
<affiliation><nlm:affiliation>University of California, San Francisco, San Francisco, CA.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Annals of neurology</title>
<idno type="eISSN">1531-8249</idno>
<imprint><date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Almost half the cells and 1% of the unique genes found in our bodies are human, the rest are from microbes, predominantly bacteria, archaea, fungi, and viruses. These microorganisms collectively form the human microbiota, with most colonizing the gut. Recent technological advances, open access data libraries, and application of high-throughput sequencing have allowed these microbes to be identified and their contribution to neurological health to be examined. Emerging evidence links perturbations in the gut microbiota to neurological disease, including disease risk, activity, and progression. This review provides an overview of the recent advances in microbiome research in relation to neuro(auto)immune and neurodegenerative conditions affecting humans, such as multiple sclerosis, neuromyelitis optica spectrum disorders, Parkinson disease, Alzheimer disease, Huntington disease, and amyotrophic lateral sclerosis. Study design and terminology used in this rapidly evolving, highly multidisciplinary field are summarized to empower and engage the neurology community in this "newly discovered organ." Ann Neurol 2017;81:369-382.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">28220542</PMID>
<DateCreated><Year>2017</Year>
<Month>02</Month>
<Day>21</Day>
</DateCreated>
<DateRevised><Year>2017</Year>
<Month>03</Month>
<Day>25</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-8249</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>81</Volume>
<Issue>3</Issue>
<PubDate><Year>2017</Year>
<Month>Mar</Month>
</PubDate>
</JournalIssue>
<Title>Annals of neurology</Title>
<ISOAbbreviation>Ann. Neurol.</ISOAbbreviation>
</Journal>
<ArticleTitle>The gut microbiome in human neurological disease: A review.</ArticleTitle>
<Pagination><MedlinePgn>369-382</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/ana.24901</ELocationID>
<Abstract><AbstractText>Almost half the cells and 1% of the unique genes found in our bodies are human, the rest are from microbes, predominantly bacteria, archaea, fungi, and viruses. These microorganisms collectively form the human microbiota, with most colonizing the gut. Recent technological advances, open access data libraries, and application of high-throughput sequencing have allowed these microbes to be identified and their contribution to neurological health to be examined. Emerging evidence links perturbations in the gut microbiota to neurological disease, including disease risk, activity, and progression. This review provides an overview of the recent advances in microbiome research in relation to neuro(auto)immune and neurodegenerative conditions affecting humans, such as multiple sclerosis, neuromyelitis optica spectrum disorders, Parkinson disease, Alzheimer disease, Huntington disease, and amyotrophic lateral sclerosis. Study design and terminology used in this rapidly evolving, highly multidisciplinary field are summarized to empower and engage the neurology community in this "newly discovered organ." Ann Neurol 2017;81:369-382.</AbstractText>
<CopyrightInformation>© 2017 American Neurological Association.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tremlett</LastName>
<ForeName>Helen</ForeName>
<Initials>H</Initials>
<AffiliationInfo><Affiliation>Faculty of Medicine (Neurology) and the Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bauer</LastName>
<ForeName>Kylynda C</ForeName>
<Initials>KC</Initials>
<AffiliationInfo><Affiliation>Microbiology and Immunology, Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Appel-Cresswell</LastName>
<ForeName>Silke</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Faculty of Medicine (Neurology) and the Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Pacific Parkinson's Research Centre, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Finlay</LastName>
<ForeName>Brett B</ForeName>
<Initials>BB</Initials>
<AffiliationInfo><Affiliation>Microbiology and Immunology, Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Waubant</LastName>
<ForeName>Emmanuelle</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>University of California, San Francisco, San Francisco, CA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2017</Year>
<Month>03</Month>
<Day>20</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Ann Neurol</MedlineTA>
<NlmUniqueID>7707449</NlmUniqueID>
<ISSNLinking>0364-5134</ISSNLinking>
</MedlineJournalInfo>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year>
<Month>11</Month>
<Day>29</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2017</Year>
<Month>02</Month>
<Day>17</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2017</Year>
<Month>02</Month>
<Day>17</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2017</Year>
<Month>2</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2017</Year>
<Month>2</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2017</Year>
<Month>2</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">28220542</ArticleId>
<ArticleId IdType="doi">10.1002/ana.24901</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000042 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000042 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Canada |area= ParkinsonCanadaV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:28220542 |texte= The gut microbiome in human neurological disease: A review. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:28220542" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a ParkinsonCanadaV1
This area was generated with Dilib version V0.6.29. |